2024
Venous Thromboembolism Prophylaxis in Pregnancy: Why are the U.S. and European Guidelines so Different? Recent Studies and Clinical Insights
Piacquadio M, Paidas M. Venous Thromboembolism Prophylaxis in Pregnancy: Why are the U.S. and European Guidelines so Different? Recent Studies and Clinical Insights. Current Obstetrics And Gynecology Reports 2024, 14: 3. DOI: 10.1007/s13669-024-00407-9.Peer-Reviewed Original ResearchLow-molecular-weight heparinVenous thromboembolism prophylaxisVenous thromboembolismObstetric patientsEuropean guidelinesPostpartum periodHospitalized obstetric patientsMolecular weight heparinMechanical VTE prophylaxisVTE risk stratificationRandomized controlled studyObstetric populationPregnant populationRisk stratificationThromboembolism prophylaxisVTE prophylaxisInstitutional protocolMechanical prophylaxisWeight heparinProphylaxisAnticoagulant agentsPregnancyPoor adherenceControlled studiesPatients
2020
Thromboembolism
Paidas M. Thromboembolism. 2020, 181-200. DOI: 10.1002/9781119635307.ch19.Peer-Reviewed Original ResearchDeep venous thrombosisVenous thromboembolismRisk of DVTRisk of VTETransient hypercoagulable stateLeft lower extremityPrimary diagnostic modalitySystemic coagulationThromboembolic eventsNonpregnant womenFetal risksHypercoagulable stateVenous thrombosisVenous ultrasoundHemostatic challengesPregnant womenVascular traumaRisk factorsLower extremitiesVascular stasisDiagnostic modalitiesHormonal changesColor DopplerFibrinolytic systemPregnancy
2018
Venous thromboembolic disease
Ball B, Paidas M. Venous thromboembolic disease. 2018, 355-363. DOI: 10.1002/9781119072980.ch34.Peer-Reviewed Original Research
2014
Combined hormonal contraception and risk of venous thromboembolism within the first year following pregnancy
Petersen J, Bergholt T, Nielsen A, Paidas M, Løkkegaard E. Combined hormonal contraception and risk of venous thromboembolism within the first year following pregnancy. Thrombosis And Haemostasis 2014, 112 DOI: 10.1160/th-13-09-0797.Peer-Reviewed Original ResearchCombined hormonal contraception and risk of venous thromboembolism within the first year following pregnancy
Petersen J, Bergholt T, Nielsen A, Paidas M, Løkkegaard E. Combined hormonal contraception and risk of venous thromboembolism within the first year following pregnancy. Thrombosis And Haemostasis 2014, 112: 73-78. PMID: 24499991, DOI: 10.1160/th13-09-0797.Peer-Reviewed Original ResearchConceptsVenous thromboembolismHormonal contraceptivesIncidence ratiosFirst-time venous thromboembolismCrude incidence ratioCombined oral contraceptivesNationwide retrospective cohortConfirmed pregnanciesOral contraceptivesRetrospective cohortHormonal contraceptionPuerperal periodAbsolute riskWeeks postpartumDanish womenMAIN OUTCOMEThromboembolismPregnancyContraceptivesOne-yearUnique registryFirst yearRiskBirthRegistry
2013
347: Recombinant human antithrombin (rhAT) for prevention of venous thromboembolism (VTE) in pregnant patients with hereditary antithrombin deficiency (HD)
Paidas M, Triche E, James A, Ballard T, Lowry S. 347: Recombinant human antithrombin (rhAT) for prevention of venous thromboembolism (VTE) in pregnant patients with hereditary antithrombin deficiency (HD). American Journal Of Obstetrics And Gynecology 2013, 208: s154. DOI: 10.1016/j.ajog.2012.10.512.Peer-Reviewed Original ResearchOC-03 Oral contraception and risk of venous thromboembolism within the first year following pregnancy
Petersen J, Bergholt T, Nielsen A, Lidegaard Ø, Paidas M, Løkkegaard E. OC-03 Oral contraception and risk of venous thromboembolism within the first year following pregnancy. Thrombosis Research 2013, 131: s71. DOI: 10.1016/s0049-3848(13)70029-x.Peer-Reviewed Original Research
2009
Pulmonary embolism in pregnancy
Bourjeily G, Paidas M, Khalil H, Rosene-Montella K, Rodger M. Pulmonary embolism in pregnancy. The Lancet 2009, 375: 500-512. PMID: 19889451, DOI: 10.1016/s0140-6736(09)60996-x.Peer-Reviewed Original ResearchConceptsPulmonary embolismRisk of complicationsBest possible treatmentPotential adverse effectsAppropriate prophylaxisVenous thromboembolismRisk stratificationVenous stasisPregnant womenVascular damageVirchow's triadFetal teratogenicityMaternal mortalityPharmacological treatmentTherapeutic interventionsPregnancyPossible treatmentAccurate diagnosisDiagnostic testingRight populationAdverse effectsEmbolismMortalityPhysiological changesDiagnosis
2008
Antithrombotic Therapy and Pregnancy: Consensus Report and Recommendations for Prevention and Treatment of Venous Thromboembolism and Adverse Pregnancy Outcomes
Duhl A, Paidas M, Ural S, Branch W, Casele H, Cox-Gill J, Hamersley S, Hyers T, Katz V, Kuhlmann R, Nutescu E, Thorp J, Zehnder J. Antithrombotic Therapy and Pregnancy: Consensus Report and Recommendations for Prevention and Treatment of Venous Thromboembolism and Adverse Pregnancy Outcomes. Obstetric Anesthesia Digest 2008, 28: 137-138. DOI: 10.1097/01.aoa.0000326376.74250.dd.Peer-Reviewed Original Research
2007
Do Thrombophilias Cause Placenta-Mediated Pregnancy Complications?
Rodger M, Paidas M. Do Thrombophilias Cause Placenta-Mediated Pregnancy Complications? Seminars In Thrombosis And Hemostasis 2007, 33: 597-603. PMID: 17768692, DOI: 10.1055/s-2007-985756.Peer-Reviewed Original ResearchConceptsPlacenta-mediated pregnancy complicationsPregnancy complicationsAnticoagulant prophylaxisIntrauterine growth restrictionThrombophilic pregnanciesNeonatal morbidityPlacental abruptionVenous thromboembolismThrombophilic womenPregnancy lossGrowth restrictionClinical consequencesHigh riskThrombophiliaComplicationsCausal associationProphylaxisAssociationThromboembolismAbruptionPreeclampsiaMorbidityEvidencePregnancyNew associationsThromboembolic Disorders of Pregnancy
Paidas M, Pettker C, Lockwood C. Thromboembolic Disorders of Pregnancy. 2007, 825-848. DOI: 10.1002/9780470753293.ch47.ChaptersRecurrent adverse pregnancy outcomesAdverse pregnancy outcomesVenous thromboembolismPregnancy outcomesPregnancy treatmentPregnancy managementRisk factorsRadiation exposureAnemia risk factorsThromboembolic disordersAnticoagulationThromboembolismPregnancyThrombophiliaSurgeryDiagnosisPharmacologyWomenOutcomesTreatmentExposure